Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Colorectal Cancer: Hokkaido Gastrointestinal Cancer Study Group HGCSG0302
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 18 Jan 2014
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Irinotecan (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms IRIS
- 31 Oct 2007 The expected completion date for this trial is now 1 Dec 2007.
- 31 Oct 2007 Status changed from recruiting to in progress
- 20 Nov 2005 New trial record.